SCM

Soleus Capital Management Portfolio holdings

AUM $1.45B
1-Year Est. Return 18.23%
This Quarter Est. Return
1 Year Est. Return
+18.23%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.28B
AUM Growth
-$45.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
98
New
Increased
Reduced
Closed

Top Buys

1
+$49.6M
2
+$45.2M
3
+$41.6M
4
PRAX icon
Praxis Precision Medicines
PRAX
+$33.9M
5
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$18.7M

Top Sells

1
+$27.9M
2
+$26.8M
3
+$25.2M
4
QDEL icon
QuidelOrtho
QDEL
+$24.4M
5
ADPT icon
Adaptive Biotechnologies
ADPT
+$22.1M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AZN icon
76
AstraZeneca
AZN
$258B
– –
-409,000
BLCO icon
77
Bausch + Lomb
BLCO
$5.57B
– –
-120,500
ESTA icon
78
Establishment Labs
ESTA
$1.43B
– –
-59,400
GSK icon
79
GSK
GSK
$88.3B
– –
-10,110
LLY icon
80
Eli Lilly
LLY
$717B
– –
-11,658
MDXH icon
81
MDxHealth
MDXH
$205M
– –
-851,688
PCVX icon
82
Vaxcyte
PCVX
$5.57B
– –
-99,050
QDEL icon
83
QuidelOrtho
QDEL
$1.97B
– –
-547,082
RCKT icon
84
Rocket Pharmaceuticals
RCKT
$429M
– –
-271,659
REGN icon
85
Regeneron Pharmaceuticals
REGN
$61.4B
– –
-2,300
REPL icon
86
Replimune Group
REPL
$632M
– –
-262,500
TAK icon
87
Takeda Pharmaceutical
TAK
$44.6B
– –
-1,180,000
THC icon
88
Tenet Healthcare
THC
$17.9B
– –
-2,027
VCEL icon
89
Vericel Corp
VCEL
$1.82B
– –
-80,696
VRDN icon
90
Viridian Therapeutics
VRDN
$1.96B
– –
-45,500
WGS icon
91
GeneDx Holdings
WGS
$3.65B
– –
-4,000
XBI icon
92
SPDR S&P Biotech ETF
XBI
$6.34B
– –
0
ONC
93
BeOne Medicines Ltd
ONC
$35B
– –
-1,150
WHWK
94
Whitehawk Therapeutics
WHWK
$107M
– –
-333,227
CRNX icon
95
Crinetics Pharmaceuticals
CRNX
$4B
– –
-85,000
CSTL icon
96
Castle Biosciences
CSTL
$667M
– –
-252,917
ELV icon
97
Elevance Health
ELV
$78.8B
– –
-550
ELVN icon
98
Enliven Therapeutics
ELVN
$1.31B
– –
-75,405
1 2 3
4